prednisolone acetate has been researched along with Infectious Endophthalmitis in 25 studies
prednisolone acetate: RN given refers to cpd with locant for acetate group in position 21 & (11 beta)-isomer
Infectious Endophthalmitis: Infectious condition of the internal eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of a biodegradable microfilm with sustained release of prednisolone acetate (PA) on postoperative wound healing after experimental glaucoma filtration surgery (GFS)." | 7.77 | Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery. ( Ang, M; Foo, S; Venkatraman, SS; Wong, TT; Yan, P; Zhen, M, 2011) |
| "A single posterior subtenon injection of TA can be as effective and safe as a 4-week regimen of prednisolone acetate 1% eyedrops in controlling intraocular inflammation after PPV." | 5.12 | Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy. ( Barbosa, JC; Costa, RA; Jorge, R; Paccola, L; Scott, IU, 2007) |
| "To evaluate the effect of a biodegradable microfilm with sustained release of prednisolone acetate (PA) on postoperative wound healing after experimental glaucoma filtration surgery (GFS)." | 3.77 | Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery. ( Ang, M; Foo, S; Venkatraman, SS; Wong, TT; Yan, P; Zhen, M, 2011) |
| "The intraocular pressure was slightly higher in Group II (p<0." | 2.78 | Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components. ( Avakian, A; Brasil, A; Cunha, PA; Shinzato, FA; Tecchio, GT; Weber, SL, 2013) |
| "The rimexolone group was associated with significantly higher score for conjunctival hyperemia on days one and three (P < 0." | 2.73 | Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. ( Ardagil, A; Erbil, HH; Horoz, H; Kavuncu, S, 2008) |
| " This makes it possible to decrease the dosage and duration of topical prednisolone acetate." | 2.73 | Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. ( Akova, YA; Borazan, M; Karalezli, A, 2008) |
| " Ocular irritation, bioavailability and anti-inflammatory effects were evaluated and compared with the conventional suspension and solution eye drops." | 1.40 | Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone. ( Abdallah, OY; Abdelkader, H; Farid, RM; Gaafar, PM, 2014) |
| "Ciprofloxacin eye drops were immediately discontinued and replaced by topical artificial tear substitute and tobramycin eye drop along with prednisolone acetate." | 1.40 | Corneal deposit after topical ciprofloxacin as postoperative medication after cataract surgery. ( Mahadik, S; Vijay Zawar, S, 2014) |
| "Non-infectious endophthalmitis was reported to occur after cataract surgery or intravitreal injections." | 1.39 | Non-infectious endophthalmitis after vitrectomy. ( Cheung, N; Huang, Y; Tian, B; Wei, WB, 2013) |
| "The recurrent Candida infection affected primarily the iris and lens, rather than the retina and choroid." | 1.31 | Recurrent endogenous candidal endophthalmitis in a premature infant. ( Calvano, C; Simon, JW; Stern, JH, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 9 (36.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hecht, I | 1 |
| Taipale, C | 1 |
| Tuuminen, R | 1 |
| Cheng, YH | 1 |
| Chang, YF | 1 |
| Ko, YC | 1 |
| Liu, CJ | 1 |
| Nagpal, R | 1 |
| Chaurasia, S | 1 |
| Joseph, J | 1 |
| Tyagi, M | 1 |
| Rani, PK | 1 |
| Ramappa, M | 1 |
| Shah, R | 1 |
| Grzybowski, A | 1 |
| Kanclerz, P | 1 |
| Lytvynchuk, L | 1 |
| Huang, Y | 1 |
| Cheung, N | 1 |
| Tian, B | 1 |
| Wei, WB | 1 |
| Cunha, PA | 1 |
| Shinzato, FA | 1 |
| Tecchio, GT | 1 |
| Weber, SL | 1 |
| Brasil, A | 1 |
| Avakian, A | 1 |
| Papakostas, TD | 1 |
| Kohanim, S | 1 |
| Skondra, D | 1 |
| Lo, K | 1 |
| Chodosh, J | 1 |
| Gaafar, PM | 1 |
| Abdallah, OY | 1 |
| Farid, RM | 1 |
| Abdelkader, H | 1 |
| Nagpal, M | 1 |
| Lambat, S | 1 |
| Mehrotra, N | 1 |
| Paranjpe, G | 1 |
| Yadav, H | 1 |
| Bhardwaj, S | 1 |
| Vijay Zawar, S | 1 |
| Mahadik, S | 1 |
| Lorenz, K | 1 |
| Dick, B | 1 |
| Jehkul, A | 1 |
| Auffahrt, GU | 1 |
| Ang, M | 1 |
| Yan, P | 1 |
| Zhen, M | 1 |
| Foo, S | 1 |
| Venkatraman, SS | 1 |
| Wong, TT | 1 |
| Paccola, L | 1 |
| Jorge, R | 1 |
| Barbosa, JC | 1 |
| Costa, RA | 1 |
| Scott, IU | 2 |
| Kavuncu, S | 1 |
| Horoz, H | 1 |
| Ardagil, A | 1 |
| Erbil, HH | 1 |
| Karalezli, A | 1 |
| Borazan, M | 1 |
| Akova, YA | 1 |
| Flynn, HW | 1 |
| Feuer, W | 1 |
| Pflugfelder, SC | 1 |
| Alfonso, EC | 1 |
| Forster, RK | 1 |
| Miller, D | 1 |
| Snyder, RW | 1 |
| Siekert, RW | 1 |
| Schwiegerling, J | 1 |
| Donnenfeld, E | 1 |
| Thompson, P | 1 |
| Shah, CV | 1 |
| Jones, DB | 1 |
| Holz, ER | 1 |
| Stern, JH | 1 |
| Calvano, C | 1 |
| Simon, JW | 1 |
| Bhagat, N | 1 |
| Read, RW | 1 |
| Rao, NA | 1 |
| Smith, RE | 1 |
| Chong, LP | 1 |
| Tandon, A | 1 |
| Tay-Kearney, ML | 1 |
| Metcalf, C | 1 |
| McAllister, L | 1 |
| Diestelhorst, M | 1 |
| Aspacher, F | 1 |
| Konen, W | 1 |
| Krieglstein, GK | 1 |
| Hilgers, RD | 1 |
| Green, K | 1 |
| Paterson, CA | 1 |
| Cheeks, L | 1 |
| Slagle, T | 1 |
| Jay, WM | 1 |
| Aziz, MZ | 1 |
| Brady, SE | 1 |
| Cohen, EJ | 1 |
| Fischer, DH | 1 |
| Carlson, AN | 1 |
| Koch, DD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Multi-center, Controlled, Double-blind Study to Evaluate the Efficacy and Tolerability of a Steroid/Antibiotic Associated Treatment Following Cataract Extraction by Means of Phaco-emulsification[NCT02973880] | Phase 3 | 180 participants (Actual) | Interventional | 2017-10-15 | Completed | ||
| Dropless Pars Plana Vitrectomy Study[NCT05331664] | Phase 4 | 168 participants (Anticipated) | Interventional | 2022-07-25 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisolone acetate and Infectious Endophthalmitis
| Article | Year |
|---|---|
Diagnosis and treatment of chronic postoperative bacterial endophthalmitis.
Topics: Bacterial Infections; Cataract Extraction; Cephalosporins; Chronic Disease; Endophthalmitis; Female; | 1988 |
8 trials available for prednisolone acetate and Infectious Endophthalmitis
| Article | Year |
|---|---|
Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Double-Blind Method | 2013 |
Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy.
Topics: Anti-Inflammatory Agents; Benzeneacetamides; Dose-Response Relationship, Drug; Double-Blind Method; | 2014 |
Inflammatory response after phacoemulsification treated with 0.5% prednisolone acetate or vehicle.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract Extraction; Double-Blind Method; Endopht | 2008 |
Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy.
Topics: Aged; Anti-Inflammatory Agents; Connective Tissue; Double-Blind Method; Endophthalmitis; Female; Hum | 2007 |
Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Inflammatory Agents; Cataract Ext | 2008 |
Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification.
Topics: Aged; Anterior Chamber; Anti-Inflammatory Agents; Cataract Extraction; Conjunctiva; Endophthalmitis; | 2008 |
Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery.
Topics: Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Cell Count; Drug Adm | 2000 |
Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric study.
Topics: Administration, Topical; Aged; Aqueous Humor; Biological Transport, Active; Blood; Cataract Extracti | 1992 |
16 other studies available for prednisolone acetate and Infectious Endophthalmitis
| Article | Year |
|---|---|
Clinical outcomes for measuring inflammatory response after cataract surgery.
Topics: Anti-Inflammatory Agents; Benzeneacetamides; Cataract Extraction; Endophthalmitis; Humans; Ophthalmi | 2021 |
Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Chitosan; | 2021 |
Management of
Topics: Administration, Oral; Adult; Antifungal Agents; Candida glabrata; Candidiasis; Cornea; Drug Therapy, | 2018 |
Methods for achieving low endophthalmitis rates in phacoemulsification cataract surgery.
Topics: Benzeneacetamides; Cataract; Endophthalmitis; Finland; Humans; Levofloxacin; Phacoemulsification; Ph | 2020 |
Non-infectious endophthalmitis after vitrectomy.
Topics: Adult; Aged; Dexamethasone; Endophthalmitis; Female; Humans; Intraocular Pressure; Male; Middle Aged | 2013 |
Medical management of Alternaria keratitis with endophthalmitis in a patient with a corneal graft.
Topics: Administration, Oral; Administration, Topical; Adult; Alternaria; Alternariosis; Antifungal Agents; | 2014 |
Preparation, characterization and evaluation of novel elastic nano-sized niosomes (ethoniosomes) for ocular delivery of prednisolone.
Topics: Animals; Anti-Inflammatory Agents; Biological Availability; Chemistry, Pharmaceutical; Clove Oil; Dr | 2014 |
Corneal deposit after topical ciprofloxacin as postoperative medication after cataract surgery.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Cataract Extraction; Chemical Precipitation; C | 2014 |
Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery.
Topics: Animals; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Endophthalmitis; Female | 2011 |
Endophthalmitis associated with microbial keratitis.
Topics: Anti-Inflammatory Agents; Bacteria; Corneal Ulcer; Endophthalmitis; Eye Infections, Bacterial; Eye I | 1996 |
Microsphaeropsis olivacea keratitis and consecutive endophthalmitis.
Topics: Antifungal Agents; Aqueous Humor; Corneal Injuries; Debridement; Endophthalmitis; Eye Infections, Fu | 2001 |
Recurrent endogenous candidal endophthalmitis in a premature infant.
Topics: Amphotericin B; Betaxolol; Candida albicans; Candidiasis; Drug Therapy, Combination; Endophthalmitis | 2001 |
Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Diagnosis, Di | 2001 |
Bacillus circulans endophthalmitis.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacillaceae Infections; Bacillus; Cephalosporins; Ce | 2001 |
Ocular blood flow and vascular permeability in endotoxin-induced inflammation.
Topics: Animals; Capillary Permeability; Endophthalmitis; Endotoxins; Eye; Female; Fluorescein Angiography; | 1990 |
Endophthalmitis following Nd:YAG laser posterior capsulotomy.
Topics: Administration, Oral; Administration, Topical; Aged; Aqueous Humor; Bacterial Infections; Cataract E | 1988 |